<?xml version="1.0" encoding="UTF-8"?>
<p>In this report, we discuss the clinical features and pathogenesis of CCA, including evidence for a persistent viral infection versus a post-infectious inflammatory disease. We considered MTX as a therapeutic option for CCA, based on the current understanding of its pathogenesis and evaluated the MTX studies that have been conducted in CCA [
 <xref rid="B20-viruses-11-00289" ref-type="bibr">20</xref>]. Due to the severity and chronicity of CHIK arthritis, it is important to develop effective treatment [
 <xref rid="B21-viruses-11-00289" ref-type="bibr">21</xref>]. We are optimistic about the use of MTX in CCA, based on favorable, albeit limited, clinical data [
 <xref rid="B19-viruses-11-00289" ref-type="bibr">19</xref>,
 <xref rid="B20-viruses-11-00289" ref-type="bibr">20</xref>,
 <xref rid="B22-viruses-11-00289" ref-type="bibr">22</xref>].
</p>
